Abstract
Purpose
Current dry eye treatment includes delivering comfort agents to the eye via drops, but low bioavailability and multiple administration continues to be a barrier to effective treatment. There exists a significant unmet need for devices to treat dry eye and for more comfortable contact lenses.
Methods
Using molecular imprinting strategies with an analysis of biology, we have rationally designed and synthesized hydrogel contact lenses that can release hyaluronic acid (HA) at a controlled rate.
Results
Delayed release characteristics were significantly improved through biomimetic imprinting, as multiple functional monomers provided non-covalent complexation points within nelfilcon A gels without altering structural, mechanical, or optical properties. The diffusion coefficient of 1.2 million Dalton HA was controlled by varying the number and variety of functional monomers (increasing the variety lowered the HA diffusion coefficient 1.5 times more than single functional monomers, and 1.6 times more than nelfilcon A alone).
Conclusions
HA can be delivered from a daily disposable lens at a therapeutic rate of approximately 6 μg/h for 24 h. This is the first demonstration of imprinting a large molecular weight polymer within a hydrogel and the effect of imprinting on the reptation of the long chain macromolecule from the structure.
Similar content being viewed by others
References
R. Berkow, M. H. Beers, R. M. Bogin, and A. J. Fletcher. The Merck Manual of Medical Information. Merck Research Laboratories, New Jersey, 1997.
J. P. Gilbard. Human tear film electrolyte concentrations in health and dry-eye disease. Int. Ophthalmol. Clin. 34:27–36 (1994). doi:10.1097/00004397-199403410-00005.
S. K. Gupta, V. Gupta, S. Joshi, and R. Tandon. Subclinically dry eyes in urban Delhi: an impact of air pollution? Ophthalmologica. 216:368–371 (2002). doi:10.1159/000066183.
C. A. Paschides, M. Stefaniotou, J. Papageorgiou, P. Skourtis, and K. Psilas. Ocular surface and environmental changes. Acta. Ophthalmol. Scand. 76:74–77 (1998). doi:10.1034/j.1600-0420.1998.760113.x.
P. Wolkoff, J. K. Nojgaard, C. Franck, and P. Skov. The modern office environment desiccates the eyes? Indoor Air. 16:258–265 (2006). doi:10.1111/j.1600-0668.2006.00429.x.
R. I. Fox. Sjogren's syndrome. Lancet. 366:321–331 (2005). doi:10.1016/S0140-6736(05)66990-5.
M. J. Glasson, F. Stapleton, L. Keay, and M. D. P. Willcox. The effect of short term contact lens wear on the tear film and ocular surface characteristics of tolerant and intolerant wearers. Contact Lens & Anterior Eye. 29:41–47 (2006). doi:10.1016/j.clae.2005.12.006.
Y. Hori, P. Argueso, S. Spurr-Michaud, and I. K. Gipson. Mucins and contact lens wear. Cornea. 25:176–181 (2006). doi:10.1097/01.ico.0000177838.38873.2f.
R. L. Chalmers, and C. G. Begley. Dryness symptoms among an unselected clinical population with and without contact lens wear. Contact Lens & Anterior Eye. 29:25–30 (2006). doi:10.1016/j.clae.2005.12.004.
P. Reddy, O. Grad, and K. Rajagopalan. The Economic Burden of Dry Eye. Cornea. 23:751–761 (2004). doi:10.1097/01.ico.0000134183.47687.75.
G. Young, J. Veys, N. Pritchard, and S. Coleman. A multi-centre study of lapsed contact lens wearers. Ophthalmic Physiol. Opt. 22:516–527 (2002). doi:10.1046/j.1475-1313.2002.00066.x.
J. C. Stuart, and J. G. Linn. Dilute sodium hyaluronate (Healon) in the treatment of ocular surface disorders. Ann Ophthalmol. 17:190–192 (1985).
P. Aragona, V. Papa, A. Micali, M. Santocono, and G. Milazzo. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br. J. Ophthalmol. 86:181–184 (2002). doi:10.1136/bjo.86.2.181.
P. Aragona, G. Di Stefano, F. Ferreri, R. Spinella, and A. Stilo. Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjögren's syndrome patients. Br. J. Ophthalmol. 86:879–884 (2002). doi:10.1136/bjo.86.8.879.
F. Brignole, P. J. Pisella, B. Dupas, V. Baeyens, and C. Baudouin. Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis. Graefe's Arch. Clin. Exp. Ophthalmol. 243:531–538 (2005). doi:10.1007/s00417-004-1040-6.
T. Hamano, K. Horimoto, M. Lee, and S. Komemushi. Sodium hyaluronate eyedrops enhance tear film stability. Jpn. J. Ophthalmol. 40:62–65 (1996).
K. Tsubota, and M. Yamada. Tear evaporation from the ocular surface. Invest. Ophthalmol. Vis. Sci. 33:2942–2950 (1992).
N. Nakamura, M. Hikida, T. Nakano, S. Ito, T. Hamano, and S. Kinoshita. Characterization of water retentive properties of hyaluronan. Cornea. 12:433–436 (1993). doi:10.1097/00003226-199309000-00010.
G. Camillieri, C. Bucolo, S. Rossi, and F. Drago. Hyaluronan-induced stimulation of corneal wound healing is a pure pharmacological effect. J. Ocul. Pharmacol. Ther. 20:548–553 (2004). doi:10.1089/jop.2004.20.548.
J. A. P. Gomes, R. Amankwah, A. Powell-Richards, and H. S. Dua. Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br. J. Ophthalmol. 88:821–825 (2004). doi:10.1136/bjo.2003.027573.
J. U. Prause. Treatment of keratoconjunctivitis sicca with Lacrisert. Scand J. Rheumatol Supple. 61:261–263 (1986).
C. Delattre, P. Michaud, J. Courtois, and M. A. Vijayalakshmi. Study of specific interactions between glucuronic acid and amino acids at the interface using pseudo bioaffinity chromatography and NMR studies. Curr. Sci. 94:1279–1284 (2008).
J. S. Park, Y. B. Lim, Y. M. Kwon, B. Jeong, Y. H. Choi, and S. W. Kim. Liposome fusion induced by pH-sensitive copolymer: Poly(4-vinylpyridine-co-N,N-diethylaminoethyl methacrylate). J. Polym. Sci. Part A: Polym. Chem. 37:2305–2309 (2000). doi:10.1002/(SICI)1099-0518(19990715)37:14<2305::AID-POLA3>3.0.CO;2-5.
J. Bajorath, B. Greenfield, S. B. Munro, A. J. Day, and A. Aruffo. Identification of CD44 residues important for hyaluronan binding and delineation of the binding site. J. Biol. Chem. 273:338–343 (1998). doi:10.1074/jbc.273.1.338.
S. Willis, J. L. Court, R. P. Redman, J. Wang, S. W. Leppard, V. J. O’Byrne, S. A. Small, A. L. Lewis, S. A. Jones, and P. W. Stratford. A novel phosphorylcholine-coated contact lens for extended wear use. Biomaterials. 22:3261–3272 (2001). doi:10.1016/S0142-9612(01)00164-8.
L. C. Winterton, J. M. Lally, K. B. Sentell, and L. L. Chapoy. The elution of poly (vinyl alcohol) from a contact lens: The realization of a time release moisturizing agent/artificial tear. J. Biomed. Mater Res. B: Appl. Biomater. 80B:424–432 (2006). doi:10.1002/jbm.b.30613.
J. Nichols. Contact Lens Materials: A Look at Lubricating Agents in Daily Disposables. Contact Lens Spectrum, January (2007).
M. Van Beek, L. Jones, and H. Sheardown. Immobilized hyaluronic acid containing model silicone hydrogels reduce protein adsorption. J. Biomater. Sci., Polym. Ed. 12:1425–1436 (2008). doi:10.1163/156856208786140364.
M. Van Beek, A. Weeks, L. Jones, and H. Sheardown. Hyaluronic acid containing hydrogels for the reduction of protein adsorption. Biomaterials. 29:780–789 (2008). doi:10.1016/j.biomaterials.2007.10.039.
M. Ali. Therapeutic Contact Lenses for Comfort Molecules. Master's Thesis, Auburn University, December 2007.
M. E. Byrne, and V. Salian. Molecular Imprinting Within Hydrogels II: Progress and Analysis of the Field. Int. J. Pharm. 364:188–212 (2008). doi:10.1016/j.ijpharm.2008.09.002.
M. E. Byrne, K. Park, and N. A. Peppas. Molecular imprinting within hydrogels. Adv. Drug Del. Rev. 54:149–161 (2002). doi:10.1016/S0169-409X(01)00246-0.
J. Z. Hilt, and M. E. Byrne. Configurational biomimesis in drug delivery: molecular imprinting of biologically significant molecules. Adv. Drug Del. Rev. 56:1599–1620 (2004). doi:10.1016/j.addr.2004.04.002.
B. Sellergren, and C. J. Allender. Molecularly imprinted polymers: A bridge to advanced drug delivery. Adv. Drug Del. Rev. 57:1733–1741 (2005). doi:10.1016/j.addr.2005.07.010.
D. Cunliffe, A. Kirby, and C. Alexander. Molecularly imprinted drug delivery systems. Adv. Drug Del. Rev. 57:1836–1853 (2005).
C. Alvarez-Lorenzo, and A. Concheiro. Molecularly imprinted polymers for drug delivery. J. Chromatogr. B. 804:231–245 (2004). doi:10.1016/j.jchromb.2003.12.032.
C. J. Allender, C. Richardson, B. Woodhouse, C. M. Heard, and K. R. Brain. Pharmaceutical applications for molecularly imprinted polymers. Int. J. Pharm. 195:39–43 (2000). doi:10.1016/S0378-5173(99)00355-5.
S. Venkatesh, S. P. Sizemore, and M. E. Byrne. Biomimetic hydrogels for enhanced loading and extended release of ocular therapeutics. Biomaterials. 28:717–724 (2007). doi:10.1016/j.biomaterials.2006.09.007.
S. Venkatesh, S. P. Sizemore, J. B. Zhang, and M. E. Byrne. Therapeutic contact lenses: a biomimetic approach towards tailored ophthalmic extended delivery. Polymeric Materials: Science & Engineering (PMSE) Preprints. 94:766–767 (2006).
C. Alvarez-Lorenzo, F. Yanez, R. Barreiro-Iglesias, and A. Concheiro. Imprinted soft contact lenses as norfloxacin delivery systems. J. Controlled Release. 113:236–244 (2006). doi:10.1016/j.jconrel.2006.05.003.
H. Hiratani, Y. Mizutani, and C. Alvarez-Lorenzo. Controlling drug release from imprinted hydrogels by modifying the characteristics of the imprinted cavities. Macromol. Biosci. 5:728–733 (2005). doi:10.1002/mabi.200500065.
S. Venkatesh, J. Saha, S. Pass, and M. E. Byrne. Transport and structural analysis of molecularly imprinted hydrogels for controlled drug delivery. Eur. J. Pharm. Biopharm. 69(3):852–860 (2008). doi:10.1016/j.ejpb.2008.01.036.
C. Alvarez-Lorenzo, H. Hiratani, and A. Concheiro. Contact Lenses for Drug Delivery. Am. J. Drug Del. 4:131–151 (2006). doi:10.2165/00137696-200604030-00002.
M. Ali, and M. E. Byrne. Challenges and solutions in topical ocular drug-delivery systems. Exp. Rev. Clin. Pharmacol. 1:145–161 (2008). doi:10.1586/17512433.1.1.145.
N. Bühler, H. P. Haerr, M. Hofmann, C. Irrgang, A. Mühlebach, B. Müller, and F. Stockinger. Nelfilcon A, a New Material for Contact Lenses. Chimia. 53:269–274 (1999).
L. Michaud, and C. J. Giasson. Overwear of contact lenses: increased severity of clinical signs as a function of protein adsorption. Optom. Vis. Sci. 79:184–192 (2002). doi:10.1097/00006324-200203000-00013.
N. J. Van Haeringen. Clinical Biochemistry of Tears. Surv. Ophthalmol. 26:84–96 (1981). doi:10.1016/0039-6257(81)90145-4.
J. Crank. The Mathematics of Diffusion. Oxford University Press, Oxford, 1975.
N. A. Peppas. Hydrogels in Medicine and Pharmacy, Volumes I & II. CRC, Boca Raton, 1987.
P. J. Flory. Principles of Polymer Chemistry. Cornell University Press, Ithaca, 1953.
P. J. Flory, and J. Rehner. Statistical mechanics of cross-linked polymer networks. I. Rubberlike elasticity. J. Chem. Phys. 11:512–520 (1943). doi:10.1063/1.1723791.
P. J. Flory, and J. Rehner. Statistical mechanics of cross-linked polymer networks. II. Swelling. J. Chem. Phys. 11:521–526 (1943). doi:10.1063/1.1723792.
Z. Sklubalova, and Z. Zatloukal. Systematic study of factors affecting eye drop size and dosing variability. Pharmazie. 60:917–921 (2005).
P. G. de Gennes. Reptation of a polymer chain in the presence of fixed obstacles. J. Chem. Phys. 55:572–279 (1971). doi:10.1063/1.1675789.
Acknowledgements
We thank CIBA Vision, Inc. for funding this work and providing nefilcon macromers. We especially want to thank Dr. Lynn Winterton and Dr. John Pruitt for important discussions involving this work.
Author information
Authors and Affiliations
Corresponding author
Additional information
A research article submitted to Pharmaceutical Research for the Special Theme Section in Honor of NA Peppas.
Rights and permissions
About this article
Cite this article
Ali, M., Byrne, M.E. Controlled Release of High Molecular Weight Hyaluronic Acid from Molecularly Imprinted Hydrogel Contact Lenses. Pharm Res 26, 714–726 (2009). https://doi.org/10.1007/s11095-008-9818-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-008-9818-6